webinar register page

Webinar banner
A Big Pharma View of Emerging Technologies for Partnerships and Investment
View the webinar recording at this link:

Hear from top Big Pharma professionals in search & evaluation licensing and venture investing about what it takes to get them interested in a new technology. We will look at their recent deals and ask why they got done, explore the challenges and learn what makes a technology exciting. Then we will dive into a discussion on what tech/modalities and platforms are seen as exciting. Finally, we will get advice for those biotechs that are ready for licensing or investment. There will be live Q&A; panelists will endeavor to answer questions offline that cannot be addressed during the live Q&A. A recording will be available to registrants.

– Linda Pullan, PhD, Pullan Consulting

– Sasha Huhalov, Search & Evaluation, Oncology Lead, Takeda
– Jenny Laird, Vice-President, Neuroscience Search & Evaluation, Eli Lilly & Co.
– Chris Mortko, Head, Headquarters Search & Evaluation, Merck & Co.
– Gladys Nunez, Director, Amgen Ventures
– Jerry Shipps, Sr. Director, External Science & Innovation, Pfizer

May 26, 2022 01:00 PM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: BIO Webinars.